![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 23, 15240-15243, Aug, 1991
G von Heijne, P Liljestrom, P Mikus, H Andersson and T Ny
Plasminogen-activator inhibitor type 2 (PAI-2) is a specific inhibitor of
plasminogen activators that belongs to the serine protease inhibitor
superfamily (SERPINS). PAI-2 exists in two molecular forms: an
intracellular, non-glycosylated form and a secreted, glycosylated form.
Like ovalbumin, PAI-2 contains an uncleaved internal secretion signal. By
deletion analysis, we have mapped the secretion signal to two mildly
hydrophobic regions near the NH2 terminus. We also show that both of these
regions become more efficient translocation signals when their
hydrophobicities are increased. The PAI-2 secretion signal provides a
unique example of a signal that, by virtue of its poor efficiency, allows
the synthesis of both an extracellular and an intracellular form of the
protein.
The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity
Department of Molecular Biology, Karolinska Institute, Huddinge, Sweden.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Christoffersen, J. Ahnstrom, O. Axler, E. I. Christensen, B. Dahlback, and L. B. Nielsen The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from Plasma J. Biol. Chem., July 4, 2008; 283(27): 18765 - 18772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orsi, L. Fioriti, R. Chiesa, and R. Sitia Conditions of Endoplasmic Reticulum Stress Favor the Accumulation of Cytosolic Prion Protein J. Biol. Chem., October 13, 2006; 281(41): 30431 - 30438. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Bendtsen, L. J. Jensen, N. Blom, G. von Heijne, and S. Brunak Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel., April 1, 2004; 17(4): 349 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyakawa and T. Imamura Secretion of FGF-16 Requires an Uncleaved Bipartite Signal Sequence J. Biol. Chem., September 12, 2003; 278(37): 35718 - 35724. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, F. Maurer, and R. L. Medcalf Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation Blood, April 15, 2002; 99(8): 2810 - 2818. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Gewurz, H. L. Ploegh, and D. Tortorella US2, a Human Cytomegalovirus-encoded Type I Membrane Protein, Contains a Non-cleavable Amino-terminal Signal Peptide J. Biol. Chem., March 22, 2002; 277(13): 11306 - 11313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jankova, S. J. Harrop, D. N. Saunders, J. L. Andrews, K. C. Bertram, A. R. Gould, M. S. Baker, and P. M. G. Curmi Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center Loop J. Biol. Chem., November 9, 2001; 276(46): 43374 - 43382. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Revest, L. DeMoerlooze, and C. Dickson Fibroblast Growth Factor 9 Secretion Is Mediated by a Non-cleaved Amino-terminal Signal Sequence J. Biol. Chem., March 10, 2000; 275(11): 8083 - 8090. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyakawa, K. Hatsuzawa, T. Kurokawa, M. Asada, T. Kuroiwa, and T. Imamura A Hydrophobic Region Locating at the Center of Fibroblast Growth Factor-9 Is Crucial for Its Secretion J. Biol. Chem., October 8, 1999; 274(41): 29352 - 29357. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Dougherty, J. M. Pearson, A. Y. Yang, R. J. Westrick, M. S. Baker, and D. Ginsburg The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival PNAS, January 19, 1999; 96(2): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Antalis, M. La Linn, K. Donnan, L. Mateo, J. Gardner, J. L. Dickinson, K. Buttigieg, and A. Suhrbier The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon alpha /beta Priming J. Exp. Med., June 1, 1998; 187(11): 1799 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Pemberton, A. R. Tipton, N. Pavloff, J. Smith, J. R. Erickson, Z. M. Mouchabeck, and M. C. Kiefer Maspin Is an Intracellular Serpin That Partitions into Secretory Vesicles and Is Present at the Cell Surface J. Histochem. Cytochem., December 1, 1997; 45(12): 1697 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Jensen, T. G. Jensen, W. E. Laug, H. Hager, J. Gliemann, and B. Pepinsky The Exon 3Encoded Sequence of the Intracellular Serine Proteinase Inhibitor Plasminogen Activator Inhibitor 2Is a Protein Binding Domain J. Biol. Chem., October 25, 1996; 271(43): 26892 - 26899. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mikus and T. Ny Intracellular Polymerization of the Serpin Plasminogen Activator Inhibitor Type 2 J. Biol. Chem., April 26, 1996; 271(17): 10048 - 10053. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Scott, P. B. Coughlin, C. Bird, L. Cerruti, J. A. Hayman, and P. Bird Proteinase Inhibitor 6 Cannot Be Secreted, Which Suggests It Is a New Type of Cellular Serpin J. Biol. Chem., January 19, 1996; 271(3): 1605 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dickinson, E. J. Bates, A. Ferrante, and T. M. Antalis Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor alpha-induced Apoptosis J. Biol. Chem., November 17, 1995; 270(46): 27894 - 27904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miura, S.-i. Kawabata, Y. Wakamiya, T. Nakamura, and S. Iwanaga A Limulus Intracellular Coagulation Inhibitor Type 2 J. Biol. Chem., January 13, 1995; 270(2): 558 - 565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |